Icosavax (ICVX) Competitor Comparison
We are evaluating the key criteria listed to compare Icosavax (ICVX) against its competitors in the Biotechnology industry.
Market Capitalization
142 / 368Gross Profits
0 / 278Total Revenue
293 / 300EBITDA
205 / 337Free Cashflow
194 / 352Quick Ratio
36 / 357Earnings per Share
217 / 359Dividend yield
0 / 6Total Cash
139 / 358Performance 3 years
160 / 368Performance 5 years
179 / 368Performance 10 years
149 / 368Linearity 3 years
88 / 368Linearity 5 years
188 / 368Linearity 10 years
95 / 368Total Rank
146 / 368Dividend Rank
150 / 368Valuation Rank
139 / 368Piotroski Rank
171 / 368Muliplier Rank
358 / 368Dividend yield - ICVX ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.